Time to focus on inpatient safety: Revision of the American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards

Journal of Clinical Oncology

Volumn 30, Issue 10, 2012, Pages 1021-1022

  Jacobson, Joseph O ^a   Mulvey, Therese Marie ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Southcoast Hospitals Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; HEPARIN;

CANCER CHEMOTHERAPY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FEVER; FLUID RESUSCITATION; GASTROINTESTINAL TOXICITY; HOME CARE; HOSPITAL PATIENT; HUMAN; HYPERCALCEMIA; KIDNEY FUNCTION; NEUTROPENIA; NURSING STAFF; OUTPATIENT CARE; PATIENT CARE; PATIENT SAFETY; PHARMACY; PREMEDICATION; PRIORITY JOURNAL; RISK FACTOR; STANDARD; VENOUS THROMBOEMBOLISM;

EID: 84863938421     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.9409     Document Type: Editorial

References (24)

1. Jacobson JO, Polovich M, McNiff KK, et al: American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol 27:5469-5475, 2009
2. Dollinger M: Guidelines for Hospitalization for Chemotherapy. Oncologist 1:107-111, 1996
3. Williamson TS: The shift of oncology inpatient care to outpatient care: The challenge of retaining expert oncology nurses. Clin J Oncol Nurs 12:186-189, 2008
4. Jacobson JO, Polovich M, Gilmore TR, et al: Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Standards: Expanding the scope to include inpatient settings. J Oncol Pract 8:2-6, 2012
5. Lee YM, Hung YK, Mo FK, et al: Comparison between ambulatory infusion mode and inpatient infusion mode from the perspective of quality of life among colorectal cancer patients receiving chemotherapy. Int J Nurs Pract 16:508-516, 2010
6. Vokes EE, Schilsky RL, Choi KE, et al: A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer 63:30-36, 1989 (Pubitemid 19031977)
7. Magid DM, Vokes EE, Schilsky RL, et al: A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: Psychosocial aspects. Sele Cancer Ther 5:137-145, 1989 (Pubitemid 19247088)
8. Pasmantier MW, Coleman M, Silver RT, et al: Administration of a complex chemotherapy regimen: Inpatient versus outpatient treatment. Med Pediatr Oncol 11:333-335, 1983 (Pubitemid 14231914)
9. Aetna: Clinical Policy Bulletin: Chemotherapy, Inpatient - CPB-0570, 2011. http://www.aetna.com/cpb/medical/data/500-599/0570.html
10. Goodman M: Cisplatin: Outpatient and office hydration regimen. Semin Oncol Nursing 3:36-45, 1987 (suppl 1)
11. Tiseo M, Martelli O, Mancuso A, et al: Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma. Tumori 93:138-144, 2007 (Pubitemid 46866703)
12. Elting LS, Lu C, Escalante CP, et al: Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26:606-611, 2008 (Pubitemid 351264355)
13. Lee AY, Levine MN, Baker RI, et al: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349:146-153, 2003 (Pubitemid 36818784)
14. Major P, Lortholary A, Hon J, et al: Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 19:558-567, 2001 (Pubitemid 32112871)
15. Worth LJ, Lingaratnam S, Taylor A, et al: Use of risk stratification to guide ambulatory management of neutropenic fever: Australian Consensus Guidelines 2011 Steering Committee. Internal Med J 41:82-89, 2011
16. Lamkin L, Rosiak J, Buerhaus P, et al: Oncology Nursing Society Workforce Survey: Part I - Perceptions of the nursing workforce environment and adequacy of nurse staffing in outpatient and inpatient oncology settings. Oncol Nurs Forum 28:1545-1552, 2001
17. Berry E, Matthews KS, Singh DK, et al: An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer. Gynecol Oncol 113:63-67, 2009
18. Gutiérrez-Aguirre CH, Ruiz-Argüelles G, Cantú -Rodríguez OG, et al: Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method. Ann Hematol 89:1045-1052, 2010
19. Seamon LG, Carlson MJ, Richardson DL, et al: Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer. Int J Gynecol Cancer 19:1195-1198, 2009
20. Stiff PJ: Managing hematopoietic stem-cell transplant resources: The case for outpatient transplantation. Leuk Lymphoma 50:6-7, 2009
21. Zelcer S, Kellick M, Wexler LH, et al: The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue. Pediatr Blood Cancer 50:1176-1180, 2008 (Pubitemid 351555541)
22. Jacobson JO, Neuss MN, McNiff KK, et al: Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol 26:1893-1898, 2008
23. Neuss MN, Desch CE, McNiff KK, et al: A process for measuring the quality of cancer care: The Quality Oncology Practice Initiative. J Clin Oncol 23:6233-6239, 2005
24. McNiff KK, Bonelli KR, Jacobson JO: Quality Oncology Practice Initiative Certification Program: Overview, measure scoring methodology, and site assessment standards. J Oncol Pract 5:270-276, 2009